Dean L. Schorno

Insider Reports History

Entity
Individual
Location
301 Penobscot Drive, Redwood City, CA
Signature
/s/ Raymond Furey (Attorney-in-Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dean L. Schorno:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC EVP & Chief Financial Officer Common Stock 403K $459K $1.14 Feb 5, 2024 Direct
RIGEL PHARMACEUTICALS INC EVP & Chief Financial Officer Employee Stock Option (right to buy) 78.5K Feb 28, 2024 Direct
RIGEL PHARMACEUTICALS INC EVP & Chief Financial Officer Employee Stock Option (right to buy) 6.25K Nov 25, 2024 Direct

Insider Reports Filed by Dean L. Schorno

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RIGL RIGEL PHARMACEUTICALS INC Nov 25, 2024 1 $0 4 Nov 26, 2024 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Aug 30, 2024 1 $0 4 Sep 4, 2024 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Feb 28, 2024 2 $0 4 Mar 1, 2024 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Feb 2, 2024 2 -$14.3K 4 Feb 6, 2024 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Jan 23, 2024 2 $0 4 Jan 25, 2024 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Feb 2, 2023 1 -$8.95K 4 Feb 6, 2023 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Jan 26, 2023 3 $0 4 Jan 30, 2023 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Dec 28, 2022 1 $0 4 Dec 30, 2022 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Sep 14, 2022 1 $0 4 Sep 16, 2022 EVP & Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Jan 24, 2022 2 $0 4 Jan 26, 2022 EVP &Chief Financial Officer
RIGL RIGEL PHARMACEUTICALS INC Nov 4, 2021 1 $0 4 Nov 5, 2021 EVP & Chief Financial Officer